Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:03 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 246 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Calcification Clear all

Conditions: Osteopenia
Interventions: Low magnitude mechanical stimulation, Sham low magnitude mechanical stimulation; Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 60 Years and older
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vitamin D Deficiency, Obesity
Interventions: Not listed
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 3 Years to 12 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Osteoporosis
Interventions: Romosozumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 55 Years to 85 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 9
States / cities: Tucson, Arizona • Walnut Creek, California • Gainesville, Georgia + 6 more

Conditions: HIV Infections
Interventions: Subjects do not receive study medication in this study 202094; Drug
Lead sponsor: ViiV Healthcare; Industry
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 7
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 4 more

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Calcitonin nasal spray (salmon); Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 22 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Osteoporosis, Prostate Cancer
Interventions: dual x-ray absorptiometry; Procedure
Lead sponsor: University of Medicine and Dentistry of New Jersey; Other
Eligibility: 50 Years to 75 Years · Male only
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: New Brunswick, New Jersey

Conditions: Osteoporosis
Interventions: Teriparatide, Risedronate, Placebo, Calcium, Vitamin D; Drug · Dietary Supplement
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 50 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 6
States / cities: Fort Lauderdale, Florida • New Port Richey, Florida • Orlando, Florida + 3 more

Conditions: Chronic Kidney Disease Mineral and Bone Disorder, Cognitive Function, Vascular Calcification, Coronary Artery Calcification, Mineral and Bone Disorder (CKD-MBD), Peripheral Arterial Disease, Systemic Inflammation, Chronic Kidney Disease
Interventions: Low-dose Colchicine at 0.5mg daily, Usual Care; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 30 Years to 69 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Epilepsy
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 8 Years to 18 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2007
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Hypopituitarism, Hypogonadism, Thyroid Dysfunction, Bone Diseases, Metabolic
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 2 Years to 24 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Breast Cancer
Interventions: Zoledronic acid, Physical activity intervention; Drug · Behavioral
Lead sponsor: HealthPartners Institute; Other
Eligibility: 40 Years to 55 Years · Female only
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2007
U.S. locations: 1
States / cities: Saint Louis Park, Minnesota

Conditions: Family Member
Interventions: Bio-D-Mulsion Forte®, Placebo; Dietary Supplement · Other
Lead sponsor: University of Miami; Other
Eligibility: 55 Years and older
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Pseudoxanthoma Elasticum
Interventions: Non Interventional; Other
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoporosis
Interventions: Placebo, DP001; Drug
Lead sponsor: Deltanoid Pharmaceuticals; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 157 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 9
States / cities: Upland, California • Indianapolis, Indiana • Bethesda, Maryland + 6 more

Conditions: Adolescent Depression
Interventions: Bone Density Test; Radiation
Lead sponsor: Creighton University; Other
Eligibility: 10 Years to 17 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Healthy
Interventions: Not listed
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Metabolism
Interventions: Exercise; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 3 Years to 7 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Birmingham, Alabama

Conditions: HIV Infection, Bone Mass
Interventions: cholecalciferol plus calcium carbonate; Dietary Supplement
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 6 Years to 16 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: New York, New York

Conditions: Lactational Amenorrhea, Body Weight Changes, Bone Loss
Interventions: Exercise and dietary; Other
Lead sponsor: North Carolina Agriculture & Technical State University; Other
Eligibility: 25 Years to 40 Years · Female only
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Greensboro, North Carolina

Conditions: Osteopenia, Osteoporosis
Interventions: Pamidronate, Calcium and vitamin D; Drug
Lead sponsor: Masonic Cancer Center, University of Minnesota; Other
Eligibility: 1 Year to 20 Years
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 2
States / cities: Minneapolis, Minnesota • Seattle, Washington

Conditions: Steroid-induced Osteopor, Glucocorticoid-induced Ostepor
Interventions: Denosumab, Placebo for risendronate, Risendronate, Placebo for denosumab; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years and older
Enrollment: 795 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 18
States / cities: Birmingham, Alabama • Sacramento, California • Lakewood, Colorado + 14 more

Conditions: Kidney Failure, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder
Interventions: Oral calcitriol with cinacalcet rescue, IV activated vitamin D; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Osteoporosis
Interventions: Teriparatide, Alendronate Sodium, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 21 Years and older
Enrollment: 428 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 6
States / cities: Loma Linda, California • Palo Alto, California • Aurora, Colorado + 3 more

Conditions: End-Stage Renal Disease, Hemodialysis
Interventions: Low dialysate calcium, high dialysate calcium; Drug
Lead sponsor: Ege University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Lexington, Kentucky

Search by objective public record fields.

"VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density

Vitamin D Deficiency and Low Bone Mineral Content in Children

Transition From Alendronate to Romosozumab (AMG 785)

Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen

Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease

Bone Mineral Density and Cancer Recurrence in Patients With Early Stage Prostate Cancer

A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip Fracture

REducing Systemic Inflammation With LOw-dose Colchicine to ImproVE Cardiovascular Calcification in Chronic Kidney Disease: A Pilot Randomized Open-Label Trial

Bone Mineral Density in Pediatric Epilepsy

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

Vitamin D's Effect on Physical Performance in the Elderly

Pseudoxanthoma Elasticum (PXE) Natural History Biomarkers in PXE Individuals and Their Biological Non-PXE Siblings

Phase 2 Safety and Efficacy Study of a Vitamin D Compound (DP001) in Postmenopausal Women With Low Bone Mineral Density

Bone Mineral Content and Bone Metabolism in Adolescents on Antipsychotic Therapy

Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

Critical Periods of Exercise

The Effect of Vitamin D and Calcium on Bone in Pediatric HIV

Effects of Exercise and Yogurt on Bone Mineral Density and Immunological Factors in Human Milk: The MEEMA Study

Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation

Efficacy and Safety of Denosumab Compared With Risedronate in Individuals Taking Glucocorticoids

DePTH: De-emphasize PTH

Comparison of Teriparatide With Alendronate for Treating Glucocorticoid-Induced Osteoporosis

Effects of Lowering Dialysate Calcium Level on Progression of Coronary Artery Calcification and Bone Histomorphometry